Biofarma, a portfolio company of Ardian, has agreed to purchase 100 percent of US Pharma Lab Inc. from its founder and chairman Ashok Luhadia, its CEO Amol Luhadia and other members of the Luhadia family.

US Pharma Lab is headquartered in New Jersey and has operations in both the U.S. and China. The company is focused on the custom development, manufacture and distribution of nutraceutical products including probiotics, vitamins, minerals, supplements and dietary ingredients. The current shareholders of US Pharma Lab will reinvest a significant portion of their proceeds into an indirect parent company of Biofarma Group.

“Together, Biofarma Group and US Pharma Lab will be able to offer a variety of best-in-class technologies which are better able to serve all our customers’ needs,” comments Germano Scarpa, chairman of Biofarma Group. “The combination will also provide further opportunity to accelerate expansion into new geographic markets and develop new technological capabilities.”